Start HIV Antiretroviral Therapy ASAP, Experts Urge
WASHINGTON — Early initiation of antiretroviral therapy (ART) in patients with HIV can lead to better outcomes, especially for those ages 35 and younger, a follow-up analysis of the START trial showed. For patients who had deferred ART until their CD4 counts were below 350 cells/mm3, there was a 21% higher risk of death or […]